Knipp lab:Publications
From OpenWetWare
Recent publications
- Summary of the national institute of child health and human development-best pharmaceuticals for children act pediatric formulation initiatives workshop-pediatric biopharmaceutics classification system working group. Abdel-Rahman SM, Amidon GL, Kaul A, Lukacova V, Vinks AA, Knipp GT. Members of the BCS Task Force. Clin Ther. 2012 Nov;34(11):S11-24. doi:10.1016/j.clinthera.2012.09.014.
- Comparative pharmacokinetics studies of immediate- and modified-release formulations of glipizide in pigs and dogs. Kulkarni R, Yumibe N, Wang Z, Zhang X, Tang CC, Ruterbories K, Cox A, McCain R, Knipp GT. J Pharm Sci. 2012 Nov;101(11):4327-36. doi: 10.1002/jps.23292. Epub 2012 Aug 16.
- The effects of intralaboratory modifications to media composition and cell source on the expression of pharmaceutically relevant transporters and metabolizing genes in the Caco-2 cell line. Roth WJ, Lindley DJ, Carl SM, Knipp GT. J Pharm Sci. 2012 Oct;101(10):3962-78. doi: 10.1002/jps.23241. Epub 2012 Jul 11.
- Plasma Cortisol and Noradrenalin Concentrations in Pigs: Automated Sampling of Freely Moving Pigs Housed in the PigTurn® Versus Manually Sampled and Restrained Pigs. Marchant-Forde JN, Matthews DL, Poletto R, McCain RR, Mann DD, Degraw, RT, Hampsch JM, Peters S, Knipp GT, Kissinger CB. Anim. Welfare. 2012 May; 21(2):197-205(9).
- The effects of media on pharmaceutically relevant transporters in the human HT-29 adenocarcinoma cell line: does culture media need to be controlled? Lindley DJ, Roth WJ, Carl SM, Knipp GT. J Pharm Sci. 2012 Apr;101(4):1616-30. doi: 10.1002/jps.23036. Epub 2011 Dec 28.
- Assessing the performance of amorphous solid dispersions. Newman A, Knipp G, Zografi G. J Pharm Sci. 2012 Apr;101(4):1355-77. doi: 10.1002/jps.23031. Epub 2011 Dec 27. [Editors’ Picks and Top Ten Most Downloaded Article from June 2012-Sept 2012 on the J Pharm Sci website.]
- Editorial: Perspectives on Pediatric Drug Development. Roth WJ, Sage DP, Kulczar C, Liu W, Knipp GT. Revista Mexicana De Ciencias Farmaceuticas 2012 43(3):5-6.
- The Evaluation of Peptide/Histidine Transporter 1 (PHT1) Function: Uptake Kinetics Utilizing a COS-7 Stably Transfected Cell Line. Lindley DJ, Carl SM, Mowery S, Knipp GT. Revista Mexicana De Ciencia Farmaceuticas. Octubre-Diciembre 2011; 42(4);57-65.
- ABC and SLC transporter expression and pot substrate characterization across the human CMEC/D3 blood-brain barrier cell line. Carl SM, Lindley DJ, Couraud PO, Weksler BB, Romero I, Mowery SA, Knipp GT. Mol Pharm. 2010 Aug 2;7(4):1057-68.
- Endocrine disruptors and human health. Latini G,. Knipp G, Mantovani A, Marcovecchio ML, Chiarelli F, Soder O. Mini-Rev. Med. Chem. 2010 Aug;10(9):846-55.
- The effects of excipients on transporter mediated absorption. Goole J, Lindley DJ, Roth W, Carl SM, Amighi K, Kauffmann JM, Knipp GT. Int J Pharm. 2010 Jun 30;393(1-2):17-31. Epub 2010 Apr 24.
- Maternal di-(2-ethylhexyl)-phthalate exposure influences essential fatty acid homeostasis in rat placenta. Xu Y, Agarwal S, Cook TJ, and Knipp GT. Placenta 2008 Nov;29(11):962-9. doi: 10.1016/j.placenta.2008.08.011. Epub 2008 Sep 30.
- Effect of placental fatty acid metabolism and regulation by peroxisome proliferator activated receptor on pregnancy and fetal outcomes. Xu Y, Wang Q, Cook TJ, Knipp GT. J Pharm Sci. 2007 Oct;96(10):2582-606.
- The pharmacodynamic effects of sirolimus and sirolimus-calcineurin inhibitor combinations on macrophage scavenger and nuclear hormone receptors. Mathis AS, Jin S, Friedman GS, Peng F, Carl SM, Knipp GT. J Pharm Sci. 2007 Jan;96(1):209-22.
- Di-(2-ethylhexyl)-phthalate affects lipid profiling in fetal rat brain upon maternal exposure. Xu Y, Agrawal S, Cook TJ, Knipp GT. Arch Toxicol. 2007 Jan;81(1):57-62. Epub 2006 Sep 2.
Book Chapters
Invited Chapter:
- D.J. Lindley, S.M. Carl, D.R. Herrera-Ruiz, L.-F. Pan, L.B. Ward, J.M.E. Goole, O.S. Gudmundsson, and G.T. Knipp. Chapter 18: Drug Transporters and Their Role in Absorption and Disposition of Peptides and Peptide Based Pharmaceuticals. In Oral Bioavailability: Basic Principles, Advanced Concepts and Application. Eds. M. Hu and X. Li. In the Wiley Series on Drug Discovery and Development, Series Ed. B. Wang, John Wiley & Sons, New York, NY. pp. 291-308 (2011).
- S.M. Carl, D.J. Lindley, G.T. Knipp, K.R. Morris, E. Oliver, G.W. Becker and R.A. Arnold. Biotechnology Drug Product Development. In Pharmaceutical Manufacturing Handbook, Editor S.H. Gad, John Wiley & Sons, New York, NY, pp. 1-32 (2008). [DOI: 10.1002/9780470259818.ch1; Republished in a Wiley Special Edition Series “Pharmaceutical Sciences Encyclopedia: Drug Discovery, Development, and Manufacturing.” DOI: 10.1002/9780470571224.pse340 1-26 (2010)].
- E. Oliver, S.M. Carl, K.R. Morris, G.W. Becker and G.T. Knipp. Regulatory Considerations in the Approval of Follow-On Protein Drug Products. In Pharmaceutical Manufacturing Handbook, Editor S.H. Gad, John Wiley & Sons, New York, NY, pp. 33-57 (2008). [DOI: 10.1002/9780470259818.ch2; Republished in a Wiley Special Edition Series entitled “Pharmaceutical Sciences Encyclopedia: Drug Discovery, Development, and Manufacturing.” 1–32 (2010)].
- S.M. Carl, D.J. Lindley, G.T. Knipp, K.R. Morris, E. Oliver, G.W. Becker and R.A. Arnold, Biotechnology Drug Product Development. In Pharmaceutical Manufacturing Handbook, Editor S.H. Gad, John Wiley & Sons, New York, NY, pp. 1-32 (2008).
- E. Oliver, S.M. Carl, K.R. Morris, G.W. Becker and G.T. Knipp. Regulatory Considerations in the Approval of Follow On Protein Drug Products. In Pharmaceutical Manufacturing Handbook, Editor S.H. Gad, John Wiley & Sons, New York, NY, pp. 33-57 (2008).
- R.K. Bhardwaj, D.R. Herrera-Ruiz, Y. Xu, S.M. Carl, T.J. Cook, N. Vorsa, and G.T. Knipp. Chapter 7: Intestinal Transporters in Drug Absorption. In Biopharmaceutics Applications in Drug Development. Editors R. Krishna and L. Yu, Kluwer Press, NY, pp. 175-261 (2008).
- S.M. Carl, D.R. Herrera-Ruiz, R.K. Bhardwaj, O.S. Gudmundsson, and G.T. Knipp. Chapter 6: Mammalian Oligopeptide Transporters. In Drug Transporters: Molecular Characterization and Role in Drug Disposition. Editors G. You and M. Morris. John Wiley & Sons, New York, NY. pp. 105-146 (2007).
Edited Textbook Chapters
Martin’s Physical Pharmacy and Pharmaceutical Sciences, Fifth Edition. Editor Patrick J. Sinko. Lippincott, Williams & Wilkins, Baltimore, MD, (2006).
- G.T. Knipp and K.R. Morris, Chapter 2: States of Matter.
- H. Morelos, D. Herrera-Ruiz, and G.T. Knipp, Chapter 3: Thermodynamics.
- G.T. Knipp, H. Morelos and D. Herrera-Ruiz, Chapter 4: Physical Properties of Drug Molecules.
Refereed Abstracts
- N. Yumibe, R. Kulkarni, Z. Wang, X. Zhang, K. Ruterbories, A. Cox, R. Ajamie, C.C. Tang, G. Knipp, Robin McCain. Comparative Pharmacokinetic Studies of Immediate and Modified Release Formulations of Glipizide in Pigs and Dogs. 2011 AAPS Indiana/Ohio Discussion Group-Pharma Industry Challenges/Perspectives Symposium, Indianapolis, IN. (2011).
- W.J. Roth, C.B. Kissinger, S. Hannou, B.R. Cooper, R.R. McCain, R. Vreeman, and G.T. Knipp. Development and Testing of Novel Pediatric Formulation of Rifampicin for the Treatment of Tuberculosis (TB) in Infants and Young Children. 2011 AAPS Indiana/Ohio Discussion Group-Pharma Industry Challenges/Perspectives Symposium, Indianapolis, IN. (2011). Best Poster Award.
Posters
C.D. Kulczar and G.T. Knipp. Juvenile Pigs as Surrogates for Human Pediatrics During Preclinical Pharmacokinetic Testing: A Possible Means to Expedite Pediatric Drug Development?" 2012 PGSRM Best Poster.
<html>Hosted by <a href="http://www.openwetware.org"><img src="http://openwetware.org/images/0/01/80x15_openwetware.png" border="0" /></a></right> </html>